Dovitinib (TKI-258, CHIR-258)

Suppliers

Names

[ CAS No. ]:
405169-16-6

[ Name ]:
Dovitinib (TKI-258, CHIR-258)

[Synonym ]:
4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one
2(1H)-Quinolinone, 4-amino-5-fluoro-3-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-
Dovitinib
4-Amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one
4-Amino-5-fluor-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]chinolin-2(1H)-on
Dovitinib (TKI-258,CHIR-258)
4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one
Unii-I35H55G906
Dovitinib (TKI-258, CHIR-258)
CHIR-258
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-2-yl)quinolin-2(1H)-one
4-amino-5-fluoro-3-[6-(4-methyl-piperazin-1-yl)-1H-benzoimidazol-2-yl]-1H-quinolin-2-one
4-Amino-5-fluoro-3-[5-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-2(1H)-quinolinone
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
TKI-258
CHIR-258(Dovitinib,TKI258)
Dovitinib (TKI-258)
CHIR258 7.7G
CHIR-258(Dovitinib)

Chemical & Physical Properties

[ Density]:
1.4±0.1 g/cm3

[ Molecular Formula ]:
C21H21FN6O

[ Molecular Weight ]:
392.429

[ Exact Mass ]:
392.176086

[ PSA ]:
94.04000

[ LogP ]:
1.59

[ Index of Refraction ]:
1.691

[ Storage condition ]:
-20°C

Precursor & DownStream

Precursor

  • Ethyl 2-(5-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-2-yl)acetate
  • 2-Amino-6-fluorobenzonitrile
  • methylpiperazine
  • 5-Chloro-2-nitroaniline
  • 5-(4-Methylpiperazin-1-yl)-2-nitroaniline
  • 4-(4-Methylpiperazino)-1,2-benzenediamine

DownStream

Related Compounds

  • Dovitinib (TKI-258) Dilactic Acid
  • Dovitinib lactate
  • Dovitinib-d8
  • Dovitinib Lactate
  • (1R-cis)-1-(2,2,6-trimethylcyclohexyl)ethanone
  • Tromantadine
  • 3-({2-[4-(4-fluorophenyl)piperazin-1-yl]-2-oxoethyl}thio)-7-phenyl[1,2,4]triazolo[4,3-a]pyrazin-8(7H)-one
  • 3-[(3-fluorobenzyl)thio]-7-(3-methoxyphenyl)[1,2,4]triazolo[4,3-a]pyrazin-8(7H)-one
  • N-(3,5-dimethoxyphenyl)-2-[[7-(3-methoxyphenyl)-8-oxo-[1,2,4]triazolo[4,3-a]pyrazin-3-yl]sulfanyl]propanamide
  • 1h-Indole-1-carboxylic acid,5-[3-(4-morpholinyl)propoxy]-,1,1-dimethylethyl ester
  • 7-(4-ethoxyphenyl)-3-{[2-(4-fluorophenyl)-2-oxoethyl]sulfanyl}-7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-8-one
  • 3-((2-(3-chlorophenyl)-2-oxoethyl)thio)-7-(3,4-difluorophenyl)-[1,2,4]triazolo[4,3-a]pyrazin-8(7H)-one
  • N-cyclopentyl-2-((3-nitrobenzyl)thio)-4-oxo-3-((tetrahydrofuran-2-yl)methyl)-3,4-dihydroquinazoline-7-carboxamide
  • 2-((2-chloro-6-fluorobenzyl)thio)-N-cyclopentyl-4-oxo-3-((tetrahydrofuran-2-yl)methyl)-3,4-dihydroquinazoline-7-carboxamide
  • 2-((2-chloro-6-fluorobenzyl)thio)-4-oxo-N-propyl-3-((tetrahydrofuran-2-yl)methyl)-3,4-dihydroquinazoline-7-carboxamide
  • 1h-Indole-1-carboxylic acid,5-(4-cyanophenyl)-,1,1-dimethylethyl ester
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.